We found differential CpG methylation between IBD patients and HC within the assay A2, located at 213–368 bp upstream (relative to the gene orientation) of the TSS in the BACH2 promoter and within the assays A1 and A2, located in the CpG island 1 of the MGAT3 gene. Here, MGAT3 is linked to inflammatory bowel disease.